Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA)

Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Comprehensive Study by Type (Product Claim Advertisements, Reminder Advertisements, Help-Seeking Advertisements), Application (Pharmaceutical Companies, Pharmaceutical Factories), Channel (Traditional (Television) Players and Region - Global Market Outlook to 2027

Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Direct-to-Consumer Pharmaceutical Advertising (DTCPA)?
Pharmaceutical companies utilize a range of strategies to promote their goods and acquire market share, ranging from magazine and internet marketing to television commercials targeted directly at customers. The direct marketing of prescription medication goods to consumers rather than health care professionals is known as DTCPA. In contrast to marketing to health professionals, DTCA entails advertising and marketing pharmaceutical items directly to consumers. DTCPA raises consumer awareness of products as well as certain medical issues. They gain the ability to request alternative drugs from doctors for their medical issues.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledHealthy Ads (Australia), HARVARD POLITICAL REVIEW (United States), MDedge (United States), Wolters Kluwer Health, Inc (United States), Lippincott NursingCenter (United States), WebMD LLC. (United States), Fiercepharma (United States), Yumpu (Switzerland), AbelsonTaylor (United States) and Amura Marketing Technologies (India)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Healthy Ads (Australia), HARVARD POLITICAL REVIEW (United States), MDedge (United States), Wolters Kluwer Health, Inc (United States), Lippincott NursingCenter (United States), WebMD LLC. (United States), Fiercepharma (United States), Yumpu (Switzerland), AbelsonTaylor (United States) and Amura Marketing Technologies (India) are some of the key players that are part of study coverage.

The market study is broken down by Type (Product Claim Advertisements, Reminder Advertisements and Help-Seeking Advertisements), by Application (Pharmaceutical Companies and Pharmaceutical Factories) and major geographies with country level break-up.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) market by Type, Application and Region.

On the basis of geography, the market of Direct-to-Consumer Pharmaceutical Advertising (DTCPA) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Direct-to-Consumer Pharmaceutical Advertising (DTCPA) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 26 May 2021, WebMD Health Corp., an Internet Brands company and a leader in health information services for consumers and healthcare professionals (HCPs), announced the acquisition of ADDitude, a multi-channel platform supporting people with attention deficit hyperactivity disorder (ADHD), their caregivers, and professionals in the ADHD treatment space.



Market Trend
  • Adoption Of Digital Advertising By The Companies Owing To Internet Penetration
  • Growing Trend Of Mobile Apps-Based Advertising

Market Drivers
  • Rapid Growth in Pharmaceutical Industry

Opportunities
  • Increasing Usage Of Smartphones Is Boosting The Market
  • The Rising Popularity Of Social Media Across The World Boosting The (DTCPA) Market

Restraints
  • Costs Associated With Advertising Ads To The Costs Of Products

Challenges
  • Advertisement Fraud Is A Major Concern Among Advertisers


Key Target Audience
New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Product Claim Advertisements
  • Reminder Advertisements
  • Help-Seeking Advertisements
By Application
  • Pharmaceutical Companies
  • Pharmaceutical Factories
By Channel
  • Traditional (Television

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapid Growth in Pharmaceutical Industry
    • 3.3. Market Challenges
      • 3.3.1. Advertisement Fraud Is A Major Concern Among Advertisers
    • 3.4. Market Trends
      • 3.4.1. Adoption Of Digital Advertising By The Companies Owing To Internet Penetration
      • 3.4.2. Growing Trend Of Mobile Apps-Based Advertising
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type, Application, Channel and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) (Value)
      • 5.2.1. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Type (Value)
        • 5.2.1.1. Product Claim Advertisements
        • 5.2.1.2. Reminder Advertisements
        • 5.2.1.3. Help-Seeking Advertisements
      • 5.2.2. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Application (Value)
        • 5.2.2.1. Pharmaceutical Companies
        • 5.2.2.2. Pharmaceutical Factories
      • 5.2.3. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Channel (Value)
        • 5.2.3.1. Traditional (Television
      • 5.2.4. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) (Price)
      • 5.3.1. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Type (Price)
  • 6. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Healthy Ads (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. HARVARD POLITICAL REVIEW (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. MDedge (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Wolters Kluwer Health, Inc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lippincott NursingCenter (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. WebMD LLC. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fiercepharma (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Yumpu (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AbelsonTaylor (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Amura Marketing Technologies (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Sale, by Type, Application, Channel and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) (Value)
      • 7.2.1. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Type (Value)
        • 7.2.1.1. Product Claim Advertisements
        • 7.2.1.2. Reminder Advertisements
        • 7.2.1.3. Help-Seeking Advertisements
      • 7.2.2. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Application (Value)
        • 7.2.2.1. Pharmaceutical Companies
        • 7.2.2.2. Pharmaceutical Factories
      • 7.2.3. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Channel (Value)
        • 7.2.3.1. Traditional (Television
      • 7.2.4. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) (Price)
      • 7.3.1. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type(USD Million)
  • Table 2. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Product Claim Advertisements , by Region USD Million (2016-2021)
  • Table 3. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Reminder Advertisements , by Region USD Million (2016-2021)
  • Table 4. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Help-Seeking Advertisements , by Region USD Million (2016-2021)
  • Table 5. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Application(USD Million)
  • Table 6. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Pharmaceutical Companies , by Region USD Million (2016-2021)
  • Table 7. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Pharmaceutical Factories , by Region USD Million (2016-2021)
  • Table 8. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Channel(USD Million)
  • Table 9. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Traditional (Television , by Region USD Million (2016-2021)
  • Table 10. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2016-2021)
  • Table 11. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 12. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 13. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 14. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 15. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 16. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 17. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 18. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 19. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 20. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 21. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 22. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 23. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2016-2021)
  • Table 24. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 25. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 26. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 27. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 28. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 29. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 30. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 31. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 32. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 33. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 34. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 35. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 36. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 37. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 38. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 39. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 40. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 41. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 42. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 43. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 44. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 45. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 46. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 48. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2016-2021)
  • Table 49. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 50. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 51. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 52. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 53. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 54. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 55. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 56. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 57. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 58. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 59. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 60. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 61. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 62. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 63. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 64. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 65. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 66. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 67. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 68. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 69. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 70. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2016-2021)
  • Table 71. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 72. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 73. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 74. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 75. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 76. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 77. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 78. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 79. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 80. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2016-2021)
  • Table 81. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 82. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 83. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 84. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 85. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 86. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 87. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 88. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 89. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 90. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2016-2021)
  • Table 91. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2016-2021)
  • Table 92. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2016-2021)
  • Table 93. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type(USD/Units)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type(USD Million)
  • Table 105. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Product Claim Advertisements , by Region USD Million (2022-2027)
  • Table 106. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Reminder Advertisements , by Region USD Million (2022-2027)
  • Table 107. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Help-Seeking Advertisements , by Region USD Million (2022-2027)
  • Table 108. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Application(USD Million)
  • Table 109. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Pharmaceutical Companies , by Region USD Million (2022-2027)
  • Table 110. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Pharmaceutical Factories , by Region USD Million (2022-2027)
  • Table 111. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Channel(USD Million)
  • Table 112. Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Traditional (Television , by Region USD Million (2022-2027)
  • Table 113. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2022-2027)
  • Table 114. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 115. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 116. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 117. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 118. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 119. Brazil Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 120. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 121. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 122. Argentina Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 123. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 124. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 125. Rest of South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 126. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2022-2027)
  • Table 127. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 128. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 129. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 130. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 131. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 132. China Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 133. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 134. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 135. Japan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 136. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 137. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 138. India Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 139. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 140. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 141. South Korea Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 142. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 143. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 144. Taiwan Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 145. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 146. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 147. Australia Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 148. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 149. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 150. Rest of Asia-Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 151. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2022-2027)
  • Table 152. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 153. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 154. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 155. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 156. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 157. Germany Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 158. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 159. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 160. France Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 161. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 162. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 163. Italy Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 164. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 165. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 166. United Kingdom Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 167. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 168. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 169. Netherlands Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 170. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 171. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 172. Rest of Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 173. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2022-2027)
  • Table 174. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 175. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 176. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 177. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 178. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 179. Middle East Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 180. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 181. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 182. Africa Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 183. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Country USD Million (2022-2027)
  • Table 184. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 185. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 186. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 187. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 188. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 189. United States Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 190. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 191. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 192. Canada Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 193. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Type USD Million (2022-2027)
  • Table 194. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Application USD Million (2022-2027)
  • Table 195. Mexico Direct-to-Consumer Pharmaceutical Advertising (DTCPA), by Channel USD Million (2022-2027)
  • Table 196. Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type(USD/Units)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type USD Million (2016-2021)
  • Figure 5. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Application USD Million (2016-2021)
  • Figure 6. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Channel USD Million (2016-2021)
  • Figure 7. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 8. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 9. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 10. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 11. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 12. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type USD/Units (2016-2021)
  • Figure 13. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) share by Players 2021 (%)
  • Figure 14. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) share by Players (Top 3) 2021(%)
  • Figure 15. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Healthy Ads (Australia) Revenue, Net Income and Gross profit
  • Figure 18. Healthy Ads (Australia) Revenue: by Geography 2021
  • Figure 19. HARVARD POLITICAL REVIEW (United States) Revenue, Net Income and Gross profit
  • Figure 20. HARVARD POLITICAL REVIEW (United States) Revenue: by Geography 2021
  • Figure 21. MDedge (United States) Revenue, Net Income and Gross profit
  • Figure 22. MDedge (United States) Revenue: by Geography 2021
  • Figure 23. Wolters Kluwer Health, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 24. Wolters Kluwer Health, Inc (United States) Revenue: by Geography 2021
  • Figure 25. Lippincott NursingCenter (United States) Revenue, Net Income and Gross profit
  • Figure 26. Lippincott NursingCenter (United States) Revenue: by Geography 2021
  • Figure 27. WebMD LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 28. WebMD LLC. (United States) Revenue: by Geography 2021
  • Figure 29. Fiercepharma (United States) Revenue, Net Income and Gross profit
  • Figure 30. Fiercepharma (United States) Revenue: by Geography 2021
  • Figure 31. Yumpu (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Yumpu (Switzerland) Revenue: by Geography 2021
  • Figure 33. AbelsonTaylor (United States) Revenue, Net Income and Gross profit
  • Figure 34. AbelsonTaylor (United States) Revenue: by Geography 2021
  • Figure 35. Amura Marketing Technologies (India) Revenue, Net Income and Gross profit
  • Figure 36. Amura Marketing Technologies (India) Revenue: by Geography 2021
  • Figure 37. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type USD Million (2022-2027)
  • Figure 38. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Application USD Million (2022-2027)
  • Figure 39. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Channel USD Million (2022-2027)
  • Figure 40. South America Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 41. Asia Pacific Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 42. Europe Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 43. MEA Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 44. North America Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Share (%), by Country
  • Figure 45. Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA): by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Healthy Ads (Australia)
  • HARVARD POLITICAL REVIEW (United States)
  • MDedge (United States)
  • Wolters Kluwer Health, Inc (United States)
  • Lippincott NursingCenter (United States)
  • WebMD LLC. (United States)
  • Fiercepharma (United States)
  • Yumpu (Switzerland)
  • AbelsonTaylor (United States)
  • Amura Marketing Technologies (India)
Select User Access Type

Key Highlights of Report


May 2022 241 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Quantitative research analysis
Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Healthy Ads (Australia), HARVARD POLITICAL REVIEW (United States), MDedge (United States), Wolters Kluwer Health, Inc (United States), Lippincott NursingCenter (United States), WebMD LLC. (United States), Fiercepharma (United States), Yumpu (Switzerland), AbelsonTaylor (United States) and Amura Marketing Technologies (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Direct-to-Consumer Pharmaceutical Advertising (DTCPA) Report?

Have a Query? Click Here

Other Related Reports

Volunteer Management Software Comprehensive Study by Deployment Mode (Cloud-Based, On-Premise), Platform (PC Terminal, Mobile Terminal), Pricing (Monthly, Annually, Others), End User (Community organ...
$ 3350
Utility Management Systems Software Comprehensive Study by Application (Tracking & Monitoring, Asset Management, Billing & Invoicing, Predictive Maintenance, Customer Management, Reporting, Others), ...
$ 3800
Business Intelligence Platform Comprehensive Study by Application (Healthcare, Retail, Government, BFSI, Telecom & IT, Others), Enterprise (Small and Medium-Sized Enterprises, Large Enterprises), Dep...
$ 3350
Order Management Applications Software Comprehensive Study by Industry Verticals (Retail Industry, Telecommunications, Healthcare, Pharmaceutical, Financial, Security, Others), Pricing (Annual Subscr...
$ 3750
IC Design Service Comprehensive Study by Type (Digital Design, Custom Design, FPGA-based Design), Application (5G, Automobile, IoT, Others), Service (System Design, Design & Verification, Physical & ...
$ 3450
Corporate IP Telephony Software Comprehensive Study by Deployment Mode (Cloud-based, Web-based), Industry Vertical (IT, BFSI, Retail, Manufacturing, Other), Functions (Conference Calls, Phone Calls H...
$ 3450